Looking at that Charlie Nemeroff Miami Herald newspaper article [which was a review article-equivalent] reminded me of a graph I made in the past but never used. It was still there in my piddle-around subdirectory. It was the one on the bottom. The light green is Dr. Nemeroff’s articles/year. The darker green is the portion […]
The clock is ticking towards the end of the public comment period for the DSM-5. Only four more days before they close the comments, a centerpiece for their claim of open-ness. Will the APA post the results of their Field Trials before the comment period runs out? Or post them at all?
Medical advances helping lift the fog of depression Women are twice as likely than men to develop depression. New treatments are in the works. The Miami Herald By Lidia Dinkova June 12, 2012 About 20 years ago, Sue gave the impression that she was the poster college girl. She was pretty, slim, in a sorority, […]
speechless… an ethical guy… only one question… In the matter of Dr. Nemeroff’s NIMH Grant for $2 M, today is a day to begin wondering what Dr. Collins of the NIH [or Dr. Insel of the NIMH] will have to say to Senator Grassley "no later than June 12, 2012"… [reformatted to fit][click for the […]
Thanks to some amazing help from Suzy Chapman over at dxrevisionwatch, I’m beginning to come up to speed on the possibilities for using the international classification of diseases as a primary diagnostic resource in mental health. Over the next little while, I’m going to take a stab at compiling the resources and demystifying some confusing […]
J&J May Pay $2.2B To Settle Risperdal Probes Pharmalot by Ed Silverman June 11, 2012 After lengthy on-and-off negotiations, Johnson & Johnson has agreed to pay as much as $2.2 billion to settle various federal government probes into the marketing of the Risperdal antipsychotic, as well as other medications, Bloomberg News reports… The accord, which […]
The International Classification of Disease [ICD] began its life as a cause of death classification [vital statistics] in the mid-19th century and as gradually incorporated other functions [indexing hospital records, reimbursements, etc.] over it’s development – retaining its function as a statistical tool to the present. It’s now in its 11th Revision process. For our […]
One might think that I would tire of complaining about the DSM-5 process, but that doesn’t seem to be the case. This particular complaint is actually bigger than just the DSM-5, it’s about frequent misguided science in psychiatry in general. Here’s the DSM-5 example from January 2012: Q: Are the standards set for the reliability […]
Well this month’s Journal of Nervous and Mental Disease is certainly focused on a familiar topic for this blog – the DSM-5: Diagnostic Inflation: Causes and a Suggested Cure Batstra, Laura PhD; Frances, Allen MD There have been a striking diagnostic inflation and a corresponding increase in the use of psychotropic drugs during the past […]